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Harry L.A. Janssen
Department of Gastroenterology and Hepatology, Erasmus MC,
University Medical Center Rotterdam, Rotterdam, The NetherlandsTo the Editor:
We appreciate the letter to the editor regarding our paper on the
results of a project offering on-site hepatitis B testing to Chinese
migrants in Rotterdam [1]. To take Lai and Liao’s suggestion to
screen persons born in Taiwan before 1986 further, we would like
to recommend offering screening to all persons born in hepatitis
B endemic countries before the introduction of universal
vaccination.
Additionally, Lai and Liao rightly observe that primary care
providers could play an important role in the detection of chronic
hepatitis B infections. To achieve a substantial increase in the
number of identiﬁed patients with chronic hepatitis B, we feel
efforts should be targeted at several healthcare settings. Hwang
et al. studied ten thousand patients receiving chemotherapy
and found that only 17% were screened for hepatitis B [2]. This
shows that besides improving screening rates through outreach
programmes and interventions aimed at primary care, room for
improvement also exists in the hospital setting.t
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